Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Acura Pharma announces settlement of patent litigation with Sandoz
The Fly on the Wall
Thursday, May 22, 2014 - 8:28am
tags:
Sandoz, Novartis, Acura Pharmaceuticals, patents, Aversion, Oxceta
Pfizer, BioRestorative Therapies sign research agreement
The Fly on the Wall
Thursday, May 22, 2014 - 8:25am
tags:
Pfizer, BioRestorative Therapies, brown adipose tissue, R&D
Myriad Genetics Unveils Positive Prolaris Data
Yahoo/Zacks.com
Wednesday, May 21, 2014 - 4:13pm
tags:
Myriad Genetics, Prolaris, prostate cancer
[video]Can Abbott Laboratories Breathe Life into This Struggling Business?
Motley Fool
Wednesday, May 21, 2014 - 3:37pm
tags:
Abbott Labs, M&A, CFR
Alnylam announces publication of pre-clinical results with ALN-AS1
The Fly on the Wall
Wednesday, May 21, 2014 - 11:23am
tags:
Alnylam, ALN-AS1, hepatic porphyrias
Stryker must face class action employment claims
Mass Device
Wednesday, May 21, 2014 - 11:20am
tags:
devices, employment litigation, Stryker
3 Key Takeaways From Medtronic’s Earnings
Motley Fool
Wednesday, May 21, 2014 - 11:18am
tags:
Medtronic, earnings, devices
Merck says Zontivity approved for reduction of thrombotic cardiovascular events
The Fly on the Wall
Wednesday, May 21, 2014 - 11:16am
tags:
Merck, thrombotic cardiovascular events, Zontivity, FDA
Takeda’s Bowel Disease Drug Approved by U.S. Regulators
Bloomberg
Wednesday, May 21, 2014 - 10:26am
tags:
Takeda, FDA, Entyvio, vedolizumab, ulcerative colitis, Crohn's Disease
Valeant’s Pursuit of Allergan: Go Big or Go Home
Motley Fool
Wednesday, May 21, 2014 - 10:18am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Vertex: A Company-Defining Event Offers A Buying Opportunity
Seeking Alpha
Wednesday, May 21, 2014 - 10:16am
tags:
Vertex Pharmaceuticals, Kalydeco
Baxter provides U.S. regulatory update on HyQvia
The Fly on the Wall
Wednesday, May 21, 2014 - 10:13am
tags:
Baxter International, HyQvia, primary immunodeficiency, Halozyme
A New Kind of Free Speech: Drug Reps' Pitches to Doctors
The New Yorker
Wednesday, May 21, 2014 - 10:08am
tags:
free speech, off-label, physicians, drug reps
AstraZeneca Gets Woodford Backing of Pfizer Bid Rejection
Bloomberg
Wednesday, May 21, 2014 - 9:02am
tags:
Pfizer, M&A, AstraZeneca
Can AstraZeneca Live Up To CEO's Growth Plans? A Look At Its Pipeline
Forbes
Wednesday, May 21, 2014 - 8:52am
tags:
AstraZeneca, Pascal Soriot, pipeline
The Biggest Biotech Wins of the Week
Motley Fool
Wednesday, May 21, 2014 - 8:50am
tags:
Halozyme, Eli Lilly, Isis Pharmaceuticals
[video] Could Pfizer Turn Hostile Towards AstraZeneca?
Bloomberg
Wednesday, May 21, 2014 - 8:27am
tags:
Pfizer, AstraZeneca, M&A
Takeda Denies Hiding Diabetes Drug Risks in Nevada Trial
Bloomberg
Tuesday, May 20, 2014 - 5:38pm
tags:
Takeda, diabetes, Actos, bladder cancer
Sun Pharma response to import ban inadequate - FDA
Yahoo/Reuters
Tuesday, May 20, 2014 - 4:20pm
tags:
Sun Pharma, India, FDA, drug importation
AstraZeneca says 'absolutely clear' that Pfizer offer final, can't be raised
The Fly on the Wall
Tuesday, May 20, 2014 - 4:05pm
tags:
AstraZeneca, Pfizer, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.